Vice President, Marketing and Commercial Strategy

Eupraxia Pharmaceuticals Inc.•Seattle, WA

7d•Hybrid

About The Position

Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. Eupraxia's EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE, and EP-104IAR recently completed a Phase 2b clinical trial (SPRINGBOARD) for the treatment of pain due to knee osteoarthritis. Eupraxia Pharmaceuticals is seeking a dynamic and experienced Vice President of Marketing and Commercial Strategy with extensive experience creating marketing strategies, launching new products and driving commercial pipeline strategy. This individual will be responsible for developing all marketing strategies, focusing initially on launch readiness and commercialization in the U.S. of the lead program EP-104GI for Eosinophilic Esophagitis (EoE). As one of the first commercial hires, this position will be integral in Eupraxia's transition to a commercial stage biotechnology company.

Requirements

Bachelors’ degree in Business, Life Sciences or related field
15+ years of commercial experience in the biotech/pharmaceutical industry, with at least 5 years in a leading marketing role
Experience in sales and marketing, market strategy, launch planning, market analytics, pricing, re-imbursement and market access (PRMA)
Understanding of the healthcare ecosystem, including clinical workflows, regulatory landscapes, reimbursement environments, and therapeutic areas (e.g., GI, Immunology and/or specialty therapeutics)
A proven track record in a launch of a specialty therapeutic
Experience with forecast modeling, budget management (P&L), CRM implementation, and vendor management (agencies, data providers)
Ability to synthesize complex clinical data into a clear commercial narrative, in both written and oral formats
Highly motivated self-starter with strong initiative in identifying operational improvements
Clear communicator capable of presenting to senior management, and key external stakeholders
Proactive problem-solver who can troubleshoot equipment issues and safety concerns independently
Excellent organizational and time management skills to juggle multiple priorities
Excellent written, organizational, and analytical skills.
Continuous learner committed to staying current with development in Eupraxia’s strategic areas of interest (GI disease and EoE)
Strong vendor and supplier relationship management skills
Able and willing to travel internationally, especially between Canada, the US and Europe.

Nice To Haves

MBA or PhD is an asset.
Preferable to have both US and global experience
Experience in Gastroenterology (GI), Immunology, or Rare Disease is highly preferred
Familiarity with the Eosinophilic Esophagitis landscape, including the dynamics of endoscopy-based diagnosis and the role of allergist vs. gastroenterologist referral networks, is a significant plus

Responsibilities

Lead the development of the 3-year strategic commercial plan, ensuring alignment between Clinical, Regulatory, and Medical Affairs to support a successful launch in the US and potentially global markets.
Analyze qualitative and quantitative market data to generate a deeper understanding of the customer's needs, brand and disease issues and market potential.
Develop and implement overarching marketing strategy (brand plan) to define product positioning, support clinical development, and enhance brand awareness.
Effectively communicate core branding, marketing messages and product positioning statements within the organization.
Develop the optimal field force sizing, structure, and territory alignment models.
Manage global brand marketing budget, individual project budgets and develop annual and long-range sales and expense forecasts.
Advise on annual planning, priority setting and budget allocation.
Monitors business results against stated objectives and initiates corrective actions.
Collaborate with Market Access vendors, and eventually internal Market Access leadership to support the appropriate Phase 3 strategy and operational planning to ensure optimal PRMA and HEOR conditions for Phase 3 trails, NDA approval and product launch.
Support the development of the Health Technology Assessment and equivalent dossiers and value decks for payer presentations, ensuring clinical data is translated into economic value.
Establish the commercial analytics function, including forecasting, patient journey mapping, and performance dashboards.
Secure necessary data contracts (claims data, Rx data) to track market uptake and patient switching patterns.
Oversee global product demand forecasts for manufacturing.
Maintain a deep understanding of the GI/EoE landscape, monitoring competitor data readouts, pricing strategies, and standard-of-care shifts to adapt our commercial tactics in real-time.
Responsible for coordinating the activities and resource planning of the global Market Access, Market Research, Patient Advocacy, and Medical groups, as different teams are added, to align to the global strategy and execution of the business plan.
Partner with R&D, Clinical, Sales, Market Access, and Medical Affairs to convey consistent messaging and commercial goals.
Build relationships with Key Opinion Leaders (KOLs), patient advocacy groups, and customers.
Oversee end-to-end launch planning, marketing, and promotional strategies for new and existing assets.